In addition to regulation by VEGFs, tumor angiogenesis in TNBC is reported to be regulated in part through FAK-mediated promotion of VEGFR-2 expression, and targeting FAK has been proposed as an antiangiogenic strategy for the treatment of TNBC (35). The gene discussed is PTK2; the disease is neoplasm.